Negative Regulation of Toll-Like Receptor Signaling by NF-κB p50 Ubiquitination Blockade
- 3 August 2007
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 317 (5838) , 675-678
- https://doi.org/10.1126/science.1142953
Abstract
Toll-like receptors (TLRs) trigger the production of inflammatory cytokines and shape adaptive and innate immunity to pathogens. We report the identification of B cell leukemia (Bcl)–3 as an essential negative regulator of TLR signaling. By blocking ubiquitination of p50, a member of the nuclear factor (NF)-κB family, Bcl-3 stabilizes a p50 complex that inhibits gene transcription. As a consequence, Bcl-3–deficient mice and cells were found to be hypersensitive to TLR activation and unable to control responses to lipopolysaccharides. Thus, p50 ubiquitination blockade by Bcl-3 limits the strength of TLR responses and maintains innate immune homeostasis. These findings indicate that the p50 ubiquitination pathway can be selectively targeted to control deleterious inflammatory diseases.Keywords
This publication has 23 references indexed in Scilit:
- Tolerance to microbial TLR ligands: molecular mechanisms and relevance to diseaseInnate Immunity, 2006
- Negative regulation of Toll-like receptor-mediated immune responsesNature Reviews Immunology, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responsesNature Immunology, 2004
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Modulation of NF-κB Activity by Exchange of DimersMolecular Cell, 2003
- SOCS-1 Participates in Negative Regulation of LPS ResponsesImmunity, 2002
- IRAK-M Is a Negative Regulator of Toll-like Receptor SignalingCell, 2002
- Immunological defects in mice with a targeted disruption in Bcl-3.Genes & Development, 1997
- The proto-oncogene bcl-3 encodes an I kappa B protein.Genes & Development, 1992